Abstract
BackgroundSerum Calprotectin has been tested as a marker of disease activity in psoriatic (PsA) and rheumatoid (RA) arthritis. In RA and in PsA on TNF inhibitors in remission calprotectin correlates...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
